TABLE OF CONTENTS
|  |  |  | Volume 31, Issue 3 (January 2012) |  | In this issue
Original Articles
Corrigendum
Also new
   AOP
| Advertisement | Optimal NGS library construction at LIGHTNING speed! Create high-quality genomic libraries for any sequencing platform and achieve successful, cost-efficient next-generation sequencing experiments in 1/5th the time of competing systems. Diagenode's Bioruptor Sonicator is proven as the shearing device of choice providing optimal yields, quality, and fragment size at the industry's best value. Learn how Diagenode will maximize your sequencing results. |
|
|  |  | Advertisement |  | Continuing a tradition of excellence Oncogene, now in its 24th year of publication, continues to present the most essential developments in cancer research.
Visit Oncogene's website now! |
|  | | Original Articles | Top |  | Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cellsG Bulut, S-H Hong, K Chen, E M Beauchamp, S Rahim, G W Kosturko, E Glasgow, S Dakshanamurthy, H-S Lee, I Daar, J A Toretsky, C Khanna and A Üren Oncogene 2012 31: 269-281; advance online publication, June 27, 2011; 10.1038/onc.2011.245 Abstract | Full Text |  |  |  | β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expressionS K Shenoy, S Han, Y L Zhao, M R Hara, T Oliver, Y Cao and M W Dewhirst Oncogene 2012 31: 282-292; advance online publication, June 20, 2011; 10.1038/onc.2011.238 Abstract | Full Text |  |  |  | Identification and angiogenic role of the novel tumor endothelial marker CLEC14AM Mura, R K Swain, X Zhuang, H Vorschmitt, G Reynolds, S Durant, J F J Beesley, J M J Herbert, H Sheldon, M Andre, S Sanderson, K Glen, N-T Luu, H M McGettrick, P Antczak, F Falciani, G B Nash, Z S Nagy and R Bicknell Oncogene 2012 31: 293-305; advance online publication, June 27, 2011; 10.1038/onc.2011.233 Abstract | Full Text |  |  |  | Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migrationY Luo, C Zheng, J Zhang, D Lu, J Zhuang, S Xing, J Feng, D Yang and X Yan Oncogene 2012 31: 306-321; advance online publication, July 4, 2011; 10.1038/onc.2011.244 Abstract | Full Text |  |  |  | A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53J Kim, M Roh, I Doubinskaia, G N Algarroba, I-E A Eltoum and S A Abdulkadir Oncogene 2012 31: 322-332; advance online publication, June 20, 2011; 10.1038/onc.2011.236 Abstract | Full Text |  |  |  | Identification and functional analysis of 9p24 amplified genes in human breast cancerJ Wu, S Liu, G Liu, A Dombkowski, J Abrams, R Martin-Trevino, M S Wicha, S P Ethier and Z-Q Yang Oncogene 2012 31: 333-341; advance online publication, June 13, 2011; 10.1038/onc.2011.227 Abstract | Full Text |  |  |  | Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation inductionM Katsurano, T Niwa, Y Yasui, Y Shigematsu, S Yamashita, H Takeshima, M S Lee, Y-J Kim, T Tanaka and T Ushijima Oncogene 2012 31: 342-351; advance online publication, June 20, 2011; 10.1038/onc.2011.241 Abstract | Full Text |  |  |  | Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptorA Girnita, H Zheng, A Grönberg, L Girnita and M Ståhle Oncogene 2012 31: 352-365; advance online publication, June 20, 2011; 10.1038/onc.2011.239 Abstract | Full Text |  |  |  | Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitorM A Rego, J A Harney, M Mauro, M Shen and N G Howlett Oncogene 2012 31: 366-375; advance online publication, June 20, 2011; 10.1038/onc.2011.237 Abstract | Full Text |  |  |  | Rack1 promotes epithelial cell–cell adhesion by regulating E-cadherin endocytosisG Swaminathan and C A Cartwright Oncogene 2012 31: 376-389; advance online publication, June 20, 2011; 10.1038/onc.2011.242 Abstract | Full Text |  |  |  | Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformationD P Mathiasen, C Egebjerg, S H Andersen, B Rafn, P Puustinen, A Khanna, M Daugaard, E Valo, S Tuomela, T Bøttzauw, C F Nielsen, B M Willumsen, S Hautaniemi, R Lahesmaa, J Westermarck, M Jäättelä and T Kallunki Oncogene 2012 31: 390-401; advance online publication, June 27, 2011; 10.1038/onc.2011.230 Abstract | Full Text |  | Corrigendum | Top |  | Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinomaJ Kang, P X Qian, V Pandey, J K Perry, L D Miller, E T Liu, T Zhu, D X Liu and P E Lobie Oncogene 2012 31: 402; 10.1038/onc.2011.553 Full Text |  |  |  | Advertisement |  | Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function.
Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper. |
|  | |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | |
|
|
No comments:
Post a Comment